Michael L Cheng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Postmenopausal Women

Top Venues

Advances in therapy

Cancer immunology research

JCO precision oncology

CA: a cancer journal for clinicians

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
Correction to: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600EMutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune modulation with RANKL blockade through denosumab treatment in patients with cancer. Cancer immunology research (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
Correction to: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600EMutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Hewitt Chang, Jaqueline Marquez Garcia, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D Chow, Mark Bridge, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Mark S Anderson, Lawrence Fong
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer immunology research 12 (4) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy 41 (7) (2024)
Christina Baik, Michael L Cheng, Martin Dietrich, Jhanelle E Gray, Nagla Abdel Karim
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. Advances in therapy (2024)
Michael L Cheng, Yeying Huang, Nhi Luong, Jaclyn LoPiccolo, Mizuki Nishino, Lynette M Sholl, Lucian R Chirieac, Alison D Santucci, Michael S Rabin, Pasi A Janne, Shodeinde Coker, Jennifer R Diamond, John Hilton, Geoffrey I Shapiro, Christopher A French
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation. JCO precision oncology 7 (2023)
Biagio Ricciuti, Arielle Elkrief, Joao M Victor Alessi, Xinan Wang, Yvonne Y Li, Hersh V Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana P Barrichello, Victor R Vaz, Malini M Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James R Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniak, Scott J Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Cheng
Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael L Cheng, Marina S D Milan, Rubii M Tamen, Arrien A Bertram, Kesi S Michael, Biagio Ricciuti, Kenneth L Kehl, Mark M Awad, Lynette M Sholl, Cloud P Paweletz, Pasi A Jänne
Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLC. JCO precision oncology 5 (2022)
Michael L Cheng, Jessica K Lee, Rachit Kumar, Harry Klein, Kira Raskina, Alexa B Schrock, Kesi S Michael, Tali Mazor, Ethan Cerami, Geoffrey R Oxnard, David R Liu, Himisha Beltran, Lynette M Sholl, Mizuki Nishino, Pasi A Janne
Response to MEK Inhibitor Therapy in MAP2K1 ( MEK1 ) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer. JCO precision oncology 6 (2022)
Michael L Cheng, Christie J Lau, Marina S D Milan, Julianna G Supplee, Jonathan W Riess, Penelope A Bradbury, Pasi A Jänne, Geoffrey R Oxnard, Cloud P Paweletz
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC. JCO precision oncology 5 (2021)
Michael L Cheng, Eirini Pectasides, Glenn J Hanna, Heather A Parsons, Atish D Choudhury, Geoffrey R Oxnard
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions. CA: a cancer journal for clinicians 71 (2) (2020)